Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Mol Cell Cardiol ; 50(3): 426-32, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20807543

RESUMO

Plasminogen activator inhibitor-1 (PAI-1) is an oxidant-sensitive protease inhibitor that is inactivated by oxidation and has a critical role in ventricular remodeling post myocardial infarction (MI). PAI-1 knockout (KO) mice die within 7days of myocardial infarction post MI due to increased plasmin activity leading to ventricular rupture. The goal of this study was to assess the relevant pathways of leukocyte-derived oxidants post MI that alter PAI-1 activity. Transplantation of wild-type (WT) bone marrow into PAI-1 null mice prolonged survival after MI (WT marrow: 41.66% vs. PAI-1 KO marrow: 0% in PAI-1 KO mice at day 7 (p<0.02). To determine relevant enzyme systems, we transplanted marrow from mice with specific deletions relevant to leukocyte-derived oxidants (NAD(P)H oxidase, iNOS, myeloperoxidase (MPO)) to determine which deletion controls PAI-1 oxidative inactivation and prolongs survival. MI was induced by ligation of the left anterior descending artery (LAD) and the incidence of cardiac rupture was monitored. PAI-1 KO transplanted with MPO KO, or iNOS KO bone marrow died within 9 days after MI. PAI-1 KO mice transplanted with p47(phox) KO marrow exhibited prolonged survival 21 days after MI (30% survival, p<0.03, n=10) compared to WT marrow (8.3%, n=12). Three days after MI, PAI-1 KO mice transplanted with p47(phox) KO marrow had increased PAI-1 activity and decreased nitration of PAI-1 in myocardial tissue compared to PAI-1 KO mice transplanted with WT marrow. These data suggest that modulating O(2)(•-) generation by NAD(P)H oxidase appears to be a therapeutically relevant target for increasing myocardial PAI-1 levels after MI, whereas downstream enzymes like MPO and iNOS may not be.


Assuntos
Ruptura Cardíaca Pós-Infarto/metabolismo , Ruptura Cardíaca/metabolismo , Ventrículos do Coração/patologia , Leucócitos/metabolismo , NADPH Oxidases/sangue , Inibidor 1 de Ativador de Plasminogênio/metabolismo , Animais , Transplante de Medula Óssea , Ruptura Cardíaca/enzimologia , Ruptura Cardíaca/patologia , Ruptura Cardíaca Pós-Infarto/sangue , Ruptura Cardíaca Pós-Infarto/enzimologia , Ruptura Cardíaca Pós-Infarto/patologia , Leucócitos/enzimologia , Masculino , Camundongos , Camundongos Knockout , NADPH Oxidases/biossíntese , Óxido Nítrico Sintase Tipo II/metabolismo , Oxirredução , Peroxidase/metabolismo , Inibidor 1 de Ativador de Plasminogênio/sangue , Remodelação Ventricular/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA